Showing results (361-370 of 1,983) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|January 30, 2019
Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trialGil I Wolfe, Henry J Kaminski, Inmaculada B Aban, et al.The Lancet. Neurology|December 5, 2018
Stroke-heart syndrome: clinical presentation and underlying mechanismsJan F Scheitz, Christian H Nolte, Wolfram Doehner, et al.The Lancet. Neurology|December 25, 2019
Long-term safety and efficacy of closed-loop spinal cord stimulation to treat chronic back and leg pain (Evoke): a double-blind, randomised, controlled trialNagy Mekhail, Robert M Levy, Timothy R Deer, et al.The Lancet. Neurology|March 16, 2020
Initiation of pharmacological therapy in Parkinson's disease: when, why, and howRob M A de Bie, Carl E Clarke, Alberto J Espay, et al.The Lancet. Neurology|March 22, 2020
Towards a treatment for genetic prion disease: trials and biomarkersSonia M Vallabh, Eric Vallabh Minikel, Stuart L Schreiber, et al.The Lancet. Neurology|October 25, 2020
PET imaging of neuroinflammation in neurological disordersWilliam C Kreisl, Min-Jeong Kim, Jennifer M Coughlin, et al.The Lancet. Neurology|January 22, 2019
Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trialPeter A LeWitt, Robert A Hauser, Rajesh Pahwa, et al.The Lancet. Neurology|January 22, 2019
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disordersOlga Ciccarelli, Jeffrey A Cohen, Stephen C Reingold, et al.The Lancet. Neurology|November 13, 2020
New therapies for neuromyelitis optica spectrum disorderMichael Levy, Kazuo Fujihara, Jacqueline PalacePageof 199